Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Impact of Bridging Response on Outcomes after CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: March 13, 2026
Decoding lysophosphatidic acid signaling in physiology and disease: mapping the multimodal and multinodal signaling networks.
Journal: Signal transduction and targeted therapy
Published: February 06, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 30, 2025
Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma.
Journal: Research square
Published: July 16, 2024
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.
Journal: American journal of hematology
Published: June 10, 2024
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy.
Journal: Haematologica
Published: June 06, 2024
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma.
Journal: Research square
Published: February 26, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma.
Journal: Blood cancer journal
Published: January 30, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile.
Journal: British journal of haematology
Published: January 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma.
Journal: Blood cancer journal
Published: January 25, 2024
Last Updated: 09/26/2026